Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Cancer Clinical Trials: Time Series Analyses for 2012-2022 Effective diagnosis, prognostication, ...
Underlying herpes infection may have an impact on brain health in people with HIV (PWH), according to new data presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2026 ...
Hosted on MSN
Cerebrospinal fluid biomarker improves diagnosis of Parkinson's disease and Lewy body dementia
An international consortium has achieved a major breakthrough in the diagnosis of neurological diseases. In a recent publication in the journal Nature Medicine, they describe the discovery of a new ...
Researchers have uncovered a pattern of Alzheimer disease (AD) biomarker activity that differs from the accepted trajectory and could affect future clinical trials. Led by Anne M. Fagan, PhD, research ...
Biomarker changes that occur in the period between normal cognition and the diagnosis of sporadic Alzheimer’s disease have not been extensively investigated in longitudinal studies. We conducted a ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the publication of exploratory analyses on cerebrospinal fluid (CSF) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results